The DOI matches its Crossref record; 220 of the 227 references it cites were found in a registry or an index.
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Open accessAbstract
Elevated protein synthesis is an important feature of many cancer cells and often arises as a consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulator of the mRNA–ribosome recruitment phase of translation initiation. In many cellular and preclinical models of cancer, eIF4F deregulation results in changes in translational efficiency of specific mRNA classes. Importantly, many of these mRNAs code for proteins that potently regulate critical cellular processes, such as cell growth and proliferation, enhanced cell survival and cell migration that ultimately impinge on several hallmarks of cancer, including increased angiogenesis, deregulated growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and metastasis. By being positioned as the molecular nexus downstream of key oncogenic signaling pathways (e.g., Ras, PI3K/AKT/TOR, and MYC), eIF4F serves as a direct link between important steps in cancer development and translation initiation. Identification of mRNAs particularly responsive to elevated eIF4F activity that typifies tumorigenesis underscores the critical role of eIF4F in cancer and raises the exciting possibility of developing new-in-class small molecules targeting translation initiation as antineoplastic agents. Cancer Res; 75(2); 250–63. ©2014 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many direct eIF4A/eIF4F mRNA targets have been identified and often encode proteins that drive proliferation, metastasis, and survival (11, 14, 15).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.109006 · Cited by 153
RetractedPardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109006200 · Cited by 145
RetractedThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103
Self-citationA unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanismPreprint
Gingras, A., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R. H., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,348
Self-citationThe translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Self-citationPhosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
Shatkin, A. J. (1976) · Cell · doi:10.1016/0092-8674(76)90128-8 · Cited by 1,180
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 971
Self-citationSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H., de Stanchina, E., Fridman, J. S., Malina, A., Ray, S., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 956
Self-citationTranslational control in cancer
Silvera, D., Formenti, S. C., & Schneider, R. J. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2824 · Cited by 853
Morita, M., Gravel, S.-P., Chénard, V., Sikström, K., Zheng, L., Alain, T., Gandin, V., Avizonis, D., Arguello, M., Zakaria, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.001 · Cited by 842
Self-citationeIF-4E expression and its role in malignancies and metastases
Benedetti, A. D., & Graff, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207545 · Cited by 751
Self-citationS6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
Association of the yeast poly(A) tail binding protein with translation initiation factor eIF‐4G.
Tarun, S. Z., & Sachs, A. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01108.x · Cited by 699
Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP
Marcotrigiano, J., Gingras, A., Sonenberg, N., & Burley, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80280-9 · Cited by 698
Self-citationInfluences of mRNA secondary structure on initiation by eukaryotic ribosomes.
Kozak, M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2850 · Cited by 687
Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E
Pyronnet, S., Imataka, H., Gingras, A., Fukunaga, R., Hunter, T., & Sonenberg, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.270 · Cited by 639
Self-citationRNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635
Self-citationBidirectional RNA Helicase Activity of Eucaryotic Translation Initiation Factors 4A and 4F
Rozen, F., Edery, I., Meerovitch, K., Dever, T. E., Merrick, W. C., & Sonenberg, N. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1134 · Cited by 632
Self-citationMutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF‐4A.
Pause, A., & Sonenberg, N. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05330.x · Cited by 615
Self-citationPelletier, J., & Sonenberg, N. (1985) · Cell · doi:10.1016/0092-8674(85)90200-4 · Cited by 610
Self-citationThe translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W. G., Londei, P., Cordon‐Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 592
Self-citationPestova, T., & Kolupaeva, V. (2002) · Genes & Development · doi:10.1101/gad.1020902 · Cited by 590
Moerke, N. J., Aktaş, H., Chen, H., Cantel, S., Reibarkh, M., Fahmy, A., Gross, J. D., Degterev, A., Yuan, J., Chorev, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.046 · Cited by 580
The Molecular Mechanics of Eukaryotic Translation
Kapp, L. D., & Lorsch, J. R. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.030403.080419 · Cited by 565
Barrans, S., Crouch, S., Smith, A. G., Turner, K., Owen, R. G., Patmore, R. D., Roman, E., & Jack, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3947 · Cited by 552
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
Furic, L., Rong, L., Larsson, O. S., Koumakpayi, I. H., Yoshida, K., Brueschke, A., Petroulakis, E., Robichaud, N., Pollak, M., Gaboury, L. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005320107 · Cited by 541
Self-citationThe mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W. B., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 532
Self-citationMuise‐Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29864 · Cited by 512
Ueda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S., & Fukunaga, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6539-6549.2004 · Cited by 507
Proteins Encoded by the Human c-myc Oncogene: Differential Expression in Neoplastic Cells
Hann, S., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486 · Cited by 498
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
Self-citationKahvejian, A., Svitkin, Y. V., Sukarieh, R., M'Boutchou, M.-N., & Sonenberg, N. (2005) · Genes & Development · doi:10.1101/gad.1262905 · Cited by 491
Self-citationDissecting eIF4E action in tumorigenesis
Wendel, H.-G., Silva, R. L. A., Malina, A., Mills, J. R., Zhu, H., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., et al. (2007) · Genes & Development · doi:10.1101/gad.1604407 · Cited by 487
Self-citationDuncan, R., Milburn, S. C., & Hershey, J. W. B. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75938-9 · Cited by 483
Svitkin, Y. V., Pause, A., Haghighat, A., Pyronnet, S., Witherell, G. W., Belsham, G. J., & Sonenberg, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477
Self-citationWaskiewicz, A. J., Johnson, J. C., Penn, B. H., Mahalingam, M., Kimball, S. R., & Cooper, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1871 · Cited by 469
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Barna, M., Pusic, A. D., Zollo, O., Costa, M. J. D. C., Kondrashov, N., Rego, E. M., Rao, P. H., & Ruggero, D. (2008) · Nature · doi:10.1038/nature07449 · Cited by 454
Self-citationEvdokimova, V. E., Tognon, C. E., Ng, T., Ruzanov, P., Melnyk, N., Fink, D., Sorokin, A. V., Ovchinnikov, L. P., Davicioni, E., Triche, T. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.017 · Cited by 444
Hsieh, A. C., Costa, M., Zollo, O., Davis, C., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 434
Self-citationPrinciples of Translational Control: An OverviewPreprint
Hershey, J. W. B., Sonenberg, N., & Mathews, M. B. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011528 · Cited by 424
Self-citationRajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00395-2 · Cited by 420
New initiation factor activity required for globin mRNA translation.
GRIFO, J. A., Tahara, S. M., Morgan, M. A., Shatkin, A. J., & Merrick, W. C. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)81965-6 · Cited by 406
Rousseau, D. L., Kaspar, R. L., Rosenwald, I. B., Gehrke, L., & Sonenberg, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1065 · Cited by 401
Self-citationATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors.
Ray, B. K., Lawson, T. G., Kramer, J. C., Hadzopoulou‐Cladaras, M., GRIFO, J. A., Abramson, R. D., Merrick, W. C., & Thach, R. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39658-8 · Cited by 399
Graff, J., Konicek, B., Vincent, T. M., Lynch, R. L., Monteith, D., Weir, S., Schwier, P., Capen, A., Goode, R., Dowless, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32044 · Cited by 393
Self-citationeIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Boussemart, L., Malka-Mahieu, H., Girault, I., Allard, D., Hemmingsson, O., Tomasic, G., Thomas, M., Basmadjian, C., Ribeiro, N., Thuaud, F., et al. (2014) · Nature · doi:10.1038/nature13572 · Cited by 392
Structure of translation factor elF4E bound to m7GDP and interaction with 4E-binding protein
Matsuo, H., Li, H., Manson, A. L., Fletcher, C. M., Gingras, A., Sonenberg, N., & Wagner, G. (1997) · Nature Structural Biology · doi:10.1038/nsb0997-717 · Cited by 387
Self-citationA common function for mRNA 5' and 3' ends in translation initiation in yeast.Preprint
Tarun, S. Z., & Sachs, A. B. (1995) · Genes & Development · doi:10.1101/gad.9.23.2997 · Cited by 374
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
Bordeleau, M.-È., Mori, A., Oberer, M., Lindqvist, L., Chard, L. S., Higa, T., Belsham, G. J., Wagner, G., Tanaka, J., & Pelletier, J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio776 · Cited by 370
Self-citationAvdulov, S. V., Li, S., Michalek, V. N., Burrichter, D., Peterson, M., Perlman, D., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 341
Self-citationModulation of the Helicase Activity of eIF4A by eIF4B, eIF4H, and eIF4F
Rogers, G. W., Richter, N. J., Lima, W. F., & Merrick, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100157200 · Cited by 339
Rogers, G. W., Richter, N. J., & Merrick, W. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12236 · Cited by 337
Bordeleau, M.-È., Robert, F., Gerard, B., Lindqvist, L., Chen, S. M. H., Wendel, H., Brem, B., Greger, H., Lowe, S. W., Porco, J. A. J., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34753 · Cited by 335
Self-citationTargeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy
Graff, J. R., Konicek, B. W., Carter, J. H., & Marcusson, E. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5635 · Cited by 333
Self-citationL-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia
Hill, J. M. (1967) · JAMA · doi:10.1001/jama.202.9.882 · Cited by 322
Osteopontin: regulation in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9104-9 · Cited by 321
Kentsis, A., Topisirović, I., Čuljković, B., Shao, L., & Borden, K. L. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406927102 · Cited by 311
Does phosphorylation of the cap‐binding protein eIF4E play a role in translation initiation?
Scheper, G. C., & Proud, C. G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03291.x · Cited by 310
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309
Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
Cencic, R., Carrier, M., Galicia-Vázquez, G., Bordeleau, M.-E., Sukarieh, R., Bourdeau, A., Brem, B., Teodoro, J. G., Greger, H., Tremblay, M. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005223 · Cited by 302
Self-citationA Novel Functional Human Eukaryotic Translation Initiation Factor 4G
Gradi, A., Imataka, H., Svitkin, Y. V., Rom, E., Raught, B., Morino, S., & Sonenberg, N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.334 · Cited by 296
Self-citationPourdehnad, M., Truitt, M., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310230110 · Cited by 295
Self-citationImataka, H., & Sonenberg, N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.6940 · Cited by 292
Self-citationRosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N., & Schmidt, E. V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7358 · Cited by 287
Self-citation4E-Binding Protein 1: A Key Molecular “Funnel Factor” in Human Cancer with Clinical Implications
Armengol, G., Rojo, F., Castellví, J., Iglesias, C., Cuatrecasas, M., Pons, B., Baselga, J. M., & y Cajal, S. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0881 · Cited by 279
Tcherkezian, J., Cargnello, M., Roméo, Y., Huttlin, E. L., Lavoie, G., Gygi, S. P., & Roux, P. P. (2014) · Genes & Development · doi:10.1101/gad.231407.113 · Cited by 272
Topisirovic, I., Ruiz-Gutierrez, M., & Borden, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 267
Sonenberg, N., Rupprecht, K. M., Hecht, S. M., & Shatkin, A. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4345 · Cited by 261
Self-citationCunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260
Self-citationCap-Binding Proteins of Eukaryotic Messenger RNA: Functions in Initiation and Control of Translation
Sonenberg, N. (1988) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60614-5 · Cited by 259
Self-citationPhosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
Robichaud, N., Rincon, S. V. D., Huor, B., Alain, T., Petruccelli, L. A., Hearnden, J., Gonçalves, C., Grotegut, S., Spruck, C., Furic, L., et al. (2014) · Oncogene · doi:10.1038/onc.2014.146 · Cited by 259
Self-citationPhosphorylation of Eukaryotic Initiation Factor 4E Markedly Reduces Its Affinity for Capped mRNA
Scheper, G. C., van Kollenburg, B., Hu, J., Luo, Y., Goss, D. J., & Proud, C. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103607200 · Cited by 257
Rosenwald, I. B., Rhoads, D. B., Callanan, L., Isselbacher, K. J., & Schmidt, E. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6175 · Cited by 256
Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
Silvera, D., Arju, R., Darvishian, F., Levine, P. H., Zolfaghari, L., Goldberg, J. D., Hochman, T., Formenti, S. C., & Schneider, R. J. (2009) · Nature Cell Biology · doi:10.1038/ncb1900 · Cited by 251
Translational control of immune responses: from transcripts to translatomes
Piccirillo, C. A., Bjur, E., Topisirović, I., Sonenberg, N., & Larsson, O. S. (2014) · Nature Immunology · doi:10.1038/ni.2891 · Cited by 250
Self-citationKnauf, U., Tschopp, C., & Gram, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5500-5511.2001 · Cited by 249
Topology and regulation of the human eIF4A/4G/4H helicase complex in translation initiation
Marintchev, A., Edmonds, K., Marintcheva, B., Hendrickson, E., Oberer, M., Suzuki, C., Herdy, B., Sonenberg, N., & Wagner, G. (2009) · Cell · doi:10.1016/j.cell.2009.01.014 · Cited by 248
Self-citationJones, R. M., Branda, J. A., Johnston, K. A., Polymenis, M., Gadd, M. A., Rustgi, A. K., Callanan, L., & Schmidt, E. V. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4754 · Cited by 240
eIF4G Dramatically Enhances the Binding of eIF4E to the mRNA 5′-Cap Structure
Haghighat, A., & Sonenberg, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21677 · Cited by 239
Self-citationEpigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation
Mamane, Y., Petroulakis, E., Martineau, Y., Sato, T., Larsson, O. S., Rajasekhar, V. K., & Sonenberg, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000242 · Cited by 233
Self-citationBordeleau, M.-È., Matthews, J., Wojnar, J. M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P. T., Teesdale‐Spittle, P. H., & Pelletier, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504249102 · Cited by 229
Self-citationTahara, S. M., Morgan, M. A., & Shatkin, A. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43324-8 · Cited by 228
Bidirectional RNA Helicase Activity of Eucaryotic Translation Initiation Factors 4A and 4F
Rozen, F., Edery, I., Meerovitch, K., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1134-1144.1990 · Cited by 225
Involvement of eukaryotic initiation factor 4A in the cap recognition process.
Edery, I., Hümbelin, M., Darveau, A., Lee, K. A. W., Milburn, S. C., Hershey, J. W. B., Trachsel, H., & Sonenberg, N. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44431-0 · Cited by 221
Self-citationGraff, J. R., & Zimmer, S. G. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022943419011 · Cited by 219
Self-citationIlić, N., Utermark, T., Widlund, H. R., & Roberts, T. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108237108 · Cited by 217
Phosphorylation of Eukaryotic Protein Synthesis Initiation Factor 4E at Ser-209
Joshi, B., Cai, A., Keiper, B. D., Minich, W. B., Méndez, R., Beach, C. M., Stȩpiński, J., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14597 · Cited by 216
Ueda, T., Sasaki, M., Elia, A., Chio, I. I. C., Hamada, K., Fukunaga, R., & Mak, T. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008136107 · Cited by 209
Shantz, L. M., & Pegg, A. E. (1994) · PubMed · Cited by 205
Graff, J. R., Konicek, B. W., Lynch, R. L., Dumstorf, C. A., Dowless, M. S., McNulty, A. M., Parsons, S. H., Brail, L. H., Colligan, B. M., Koop, J. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3472 · Cited by 204
Self-citationRubio, C. A., Weisburd, B., Holderfield, M., Arias, C., Fang, E., DeRisi, J. L., & Fanidi, A. (2014) · Genome Biology · doi:10.1186/s13059-014-0476-1 · Cited by 200
Influence of mRNA secondary structure on binding and migration of 40S ribosomal subunits
Kozak, M. (1980) · Cell · doi:10.1016/0092-8674(80)90390-6 · Cited by 199
eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy
Ramírez‐Valle, F., Braunstein, S. E., Zavadil, J., Formenti, S. C., & Schneider, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710215 · Cited by 198
Duncan, R., & Hershey, J. W. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32356-1 · Cited by 195
Konicek, B. W., Stephens, J. R., McNulty, A. M., Robichaud, N., Peery, R. B., Dumstorf, C. A., Dowless, M. S., Iversen, P. W., Parsons, S. H., Ellis, K. E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3298 · Cited by 193
Self-citationReversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F
Cencic, R., Hall, D. R., Robert, F., Du, Y., Min, J., Li, L., Qui, M., Lewis, I., Kurtkaya, S., Dingledine, R. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011477108 · Cited by 188
Self-citationGrolleau‐Julius, A., Bowman, J., Pradet‐Balade, B., Puravs, E., Hanash, S., García‐Sanz, J. A., & Beretta, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202014200 · Cited by 187
O'Brien, S. M., Kantarjian, H. M., Keating, M., Beran, M., Koller, C. A., Robertson, L. E., Hester, J. P., Rios, M., Andreeff, M., & Talpaz, M. (1995) · Blood · doi:10.1182/blood.v86.9.3322.bloodjournal8693322 · Cited by 182
General RNA binding proteins render translation cap dependent.
Svitkin, Y. V., Ovchinnikov, L. P., Dreyfuss, G., & Sonenberg, N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01106.x · Cited by 180
Self-citationc-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
Lin, C.-J., Cencic, R., Mills, J. R., Robert, F., & Pelletier, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5876 · Cited by 180
Self-citationRosenwald, I. B., Chen, J.-J., Wang, S., Savas, L., London, I. M., & Pullman, J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202563 · Cited by 178
Parkin, N. T., Cohen, É. A., Darveau, A., Rosen, C. A., Haseltine, W. A., & Sonenberg, N. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03139.x · Cited by 177
Self-citationHuman eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity
Feoktistova, K., Tuvshintogs, E., Do, A., & Fraser, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303781110 · Cited by 177
MYC regulation of a “poor-prognosis” metastatic cancer cell state
Wolfer, A., Wittner, B. S., Irimia, D., Flavin, R., Lupien, M., Gunawardane, R. N., Meyer, C. A., Lightcap, E. S., Tamayo, P., Mesirov, J. P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914203107 · Cited by 176
Lucas, D. M., Edwards, R. B., Lozanski, G., West, D. A., Shin, J. D., Vargo, M. A., Davis, M. E., Rozewski, D. M., Johnson, A. J., Su, B., et al. (2009) · Blood · doi:10.1182/blood-2008-09-175430 · Cited by 173
Zimmer, S. G., DeBenedetti, A., & Graff, J. R. (2000) · PubMed · Cited by 167
Self-citationPolunovsky, V. A., Rosenwald, I. B., Tan, A., White, J. G., Chiang, L., Sonenberg, N., & Bitterman, P. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6573 · Cited by 165
Self-citationPDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains
Suzuki, C., Garces, R. G., Edmonds, K. A., Hiller, S., Hyberts, S. G., Marintchev, A., & Wagner, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712235105 · Cited by 165
eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
Alain, T., Morita, M., Fonseca, B. D., Yanagiya, A., Siddiqui, N., Bhat, M., Zammit, D., Marcus, V., Metrakos, P. P., Voyer, L.-A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2395 · Cited by 165
Self-citationNielsen, P. J., McMaster, G., & Trachsel, H. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.19.6867 · Cited by 159
Malignant transformation by overproduction of translation initiation factor eIF4G.
Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., EKIMOTO, H., & Igarashi, K. (1997) · PubMed · Cited by 159
Benedetti, A. D., Joshi‐Barve, S., Rinker-Schaeffer, C. W., & Rhoads, R. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5435-5445.1991 · Cited by 157
RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
Bordeleau, M.-È., Cencic, R., Lindqvist, L., Oberer, M., Northcote, P., Wagner, G., & Pelletier, J. (2006) · Chemistry and Biology · doi:10.1016/j.chembiol.2006.10.005 · Cited by 154
Self-citationFlynn, A., & Proud, C. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21684 · Cited by 152
ATP/Mg++-dependent cross-linking of cap binding proteins to the 5′ end of eukaryotic mRNA
Sonenberg, N. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.7.1643 · Cited by 150
Self-citationLawson, T. G., Ray, B. K., Dodds, J. T., GRIFO, J. A., Abramson, R. D., Merrick, W. C., Betsch, D. F., Weith, H. L., & Thach, R. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66969-8 · Cited by 147
Further Characterization of the Helicase Activity of eIF4A
Rogers, G. W., Lima, W. F., & Merrick, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007560200 · Cited by 145
DEAD-box proteins can completely separate an RNA duplex using a single ATP
Chen, Y., Potratz, J. P., Tijerina, P., Campo, M. D., Lambowitz, A. M., & Russell, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811075106 · Cited by 143
Proteins Encoded by the Human c-myc Oncogene: Differential Expression in Neoplastic Cells
Hann, S., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486-2497.1984 · Cited by 143
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen
Novac, O. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh235 · Cited by 141
The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A.
Yoder-Hill, J., Pause, A., Sonenberg, N., & Merrick, W. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53358-5 · Cited by 140
Self-citationHong, D. S., Kurzrock, R., Oh, Y. W., Wheler, J. J., Naing, A., Brail, L. H., Callies, S., André, V., KADAM, S. K., Nasir, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0430 · Cited by 140
Tomoo, K., Shen, X., Okabe, K., Nozoe, Y., Fukuhara, S., Morino, S., Ishida, T., Taniguchi, T., Hasegawa, H., Terashima, A., et al. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620539 · Cited by 139
Control of Cell Survival and Proliferation by Mammalian Eukaryotic Initiation Factor 4B
Shahbazian, D., Parsyan, A. E., Petroulakis, E., Topisirović, I., Martineau, Y., Gibbs, B. F., Svitkin, Y. V., & Sonenberg, N. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01218-09 · Cited by 137
Self-citationKevil, C. G., Carter, P. M., Hu, B., & Benedetti, A. D. (1995) · PubMed · Cited by 131
Immunophilins: Switched on protein binding domains?
Ivery, M. T. G. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200011)20:6 · Cited by 130
Zuberek, J., Wysłouch‐Cieszyńska, A., Niedźwiecka-Kornaś, A., Dadlez, M., Stȩpiński, J., Augustyniak, W., Gingras, A., ZHANG, Z., Burley, S. K., Sonenberg, N., et al. (2003) · RNA · doi:10.1261/rna.2133403 · Cited by 129
Self-citationEvidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex
Sadlish, H., Galicia-Vázquez, G., PARIS, C. G., Aust, T., Bhullar, B., Chang, L., Helliwell, S. B., Hoepfner, D., Knapp, B., Riedl, R., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400158t · Cited by 127
Self-citationWakiyama, M., Imataka, H., & Sonenberg, N. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00701-6 · Cited by 126
Self-citationBorman, A. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4068 · Cited by 125
A cellular response linking eIF4AI activity to eIF4AII transcription
Galicia-Vázquez, G., Cencic, R., Robert, F., Agenor, A., & Pelletier, J. (2012) · RNA · doi:10.1261/rna.033209.112 · Cited by 119
Self-citationBiology of tumor cell invasion: Interplay of cell adhesion and matrix degradation
Heino, J. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6 · Cited by 117
Yanagiya, A., Svitkin, Y. V., Shibata, S., Mikami, S., Imataka, H., & Sonenberg, N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01187-08 · Cited by 116
Self-citationUnique translation initiation of mRNAs-containing TISU element
Elfakess, R., Sinvani, H., Haimov, O., Svitkin, Y. V., Sonenberg, N., & Dikstein, R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr484 · Cited by 115
Self-citationLi, S., Takasu, T., Perlman, D., Peterson, M. S., Burrichter, D., Avdulov, S. V., Bitterman, P. B., & Polunovsky, V. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208821200 · Cited by 114
Graff, J. R., Boghaert, E. R., Benedetti, A. D., Tudor, D., Zimmer, C. C., Chan, S. K., & Zimmer, S. G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600221 · Cited by 114
Self-citationRinker-Schaeffer, C. W., Graff, J. R., Benedetti, A. D., Zimmer, S. G., & Rhoads, R. E. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550525 · Cited by 114
Self-citationPelletier, J., & Sonenberg, N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3222-3230.1985 · Cited by 112
Self-citationInteractions between eIF4AI and its accessory factors eIF4B and eIF4H
Rozovsky, N., Butterworth, A. C., & Moore, M. J. (2008) · RNA · doi:10.1261/rna.1049608 · Cited by 108
Blocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication
Cencic, R., Desforges, M., Hall, D. R., Kozakov, D., Du, Y., Min, J., Dingledine, R. J., Fu, H., Vajda, S., Talbot, P. J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00078-11 · Cited by 108
Self-citationMaga, G., Falchi, F., Radi, M., Botta, L., Casaluce, G., Bernardini, M., Irannejad, H., Manetti, F., Garbelli, A., Samuele, A., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100166 · Cited by 107
Altman, J. K., Szilard, A., Konicek, B. W., Iversen, P. W., Kroczyńska, B., Glaser, H., Sassano, A., Vakana, E., Graff, J. R., & Platanias, L. C. (2013) · Blood · doi:10.1182/blood-2013-01-477216 · Cited by 106
Self-citationTan, A., Bitterman, P. B., Sonenberg, N., Peterson, M., & Polunovsky, V. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203446 · Cited by 106
Self-citationKuznetsov, G., Xu, Q., Rudolph-Owen, L., TenDyke, K., Liu, J., Towle, M. J., Zhao, N., Marsh, J. P., Agoulnik, S. I., Twine, N. C., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1026 · Cited by 105
Differential stimulation of capped mRNA translation in vitro by cap binding protein
Sonenberg, N., Trachsel, H., Hecht, S. M., & Shatkin, A. J. (1980) · Nature · doi:10.1038/285331a0 · Cited by 104
Self-citationElfakess, R., & Dikstein, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003094 · Cited by 104
Tumor suppression by small molecule inhibitors of translation initiation
Chen, L., Aktas, B. H., Wang, Y., He, X., Sahoo, R., Zhang, N., Denoyelle, S., Kabha, E., Yang, H., Yefidoff‐Freedman, R., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.598 · Cited by 104
Li, S., Sonenberg, N., Gingras, A., Peterson, M., Avdulov, S. V., Polunovsky, V. A., & Bitterman, P. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2853-2861.2002 · Cited by 100
Self-citationDeterminants of Sensitivity and Resistance to Rapamycin-Chemotherapy Drug Combinations In vivo
Wendel, H., Malina, A., Zhao, Z., Zender, L., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0419 · Cited by 96
Self-citationEffects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia
Tsumuraya, T., Ishikawa, C., Machijima, Y., Nakachi, S., Senba, M., Tanaka, J., & Mori, N. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.025 · Cited by 94
Multiple elements in the eIF4G1 N‐terminus promote assembly of eIF4G1•PABP mRNPs in vivo
Park, E.-H., Walker, S. E., Lee, J. M., Rothenburg, S., Lorsch, J. R., & Hinnebusch, A. G. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.312 · Cited by 92
Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis
Lin, C., Nasr, Z., Premsrirut, P. K., Porco, J. A. J., Hippo, Y., Lowe, S. W., & Pelletier, J. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.010 · Cited by 91
Self-citationOncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress
Croft, A. J., Tay, K. H., Boyd, S. C., Guo, S., Jiang, C. C., Lai, F., Tseng, H., Jin, L., Rizos, H., Hersey, P., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.325 · Cited by 91
Shui, L., Jia, Y., Jacobson, B. A., McCauley, J. A., Kratzke, R. A., Bitterman, P. B., & Wagner, C. R. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300699d · Cited by 88
DeFatta, R. J., Nathan, C. O., & Benedetti, A. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200006000-00007 · Cited by 87
AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B
van Gorp, A. G. M., van der Vos, K. E., Brenkman, A. B., Bremer, A., van den Broek, N. J. F., Zwartkruis, F. J. T., Hershey, J. W. B., Burgering, B. M. T., Calkhoven, C. F., & Coffer, P. J. (2008) · Oncogene · doi:10.1038/onc.2008.367 · Cited by 87
Ghosh, B. K., Benyumov, A. O., Ghosh, P., Jia, Y., Avdulov, S. V., Dahlberg, P. S., Peterson, M., Smith, K. A., Polunovsky, V. A., Bitterman, P. B., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb9000475 · Cited by 86
Synthetic Silvestrol Analogues as Potent and Selective Protein Synthesis Inhibitors
Liu, T., Nair, S. J., Lescarbeau, A., Belani, J. D., Peluso, S., Conley, J., Tillotson, B. P., O’Hearn, P. J., Smith, S. A., Slocum, K. L., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011542 · Cited by 86
Diab, S., Teo, T., Kumarasiri, M., Li, P., Yu, M., Lam, F., Basnet, S. K. C., Sykes, M. J., Albrecht, H., Milne, R. W., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300552 · Cited by 85
Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E
Herbert, T. P., Fåhræus, R., Prescott, A. R., Lane, D. P., & Proud, C. G. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00567-4 · Cited by 85
Dmitriev, S. E., Terenin, I. M., Dunaevsky, Y. E., Merrick, W. C., & Shatsky, I. N. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.8925-8933.2003 · Cited by 85
Tomoo, K., Shen, X., Okabe, K., et al. (2002) · Biochemical Journal · doi:10.1042/bj3620539 · Cited by 85
Rinker-Schaeffer, C. W., Austin, V. N., Zimmer, S. G., & Rhoads, R. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50068-0 · Cited by 83
Abramson, R. D., Dever, T. E., & Merrick, W. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68741-1 · Cited by 82
Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation
Cope, C. L., Gilley, R., Balmanno, K., Sale, M. J., Howarth, K., Hampson, M., Smith, P. D., Guichard, S. M., & Cook, S. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.137588 · Cited by 82
Gupta, S. V., Sass, E. J., Davis, M. E., Edwards, R. B., Lozanski, G., Heerema, N. A., Lehman, A., Zhang, X., Jarjoura, D., Byrd, J. C., et al. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9276-7 · Cited by 81
eIF4F suppression in breast cancer affects maintenance and progression
Nasr, Z., Robert, F., Porco, J. A. J., Muller, W. J., & Pelletier, J. (2012) · Oncogene · doi:10.1038/onc.2012.105 · Cited by 81
Self-citationTargeting the eIF4A RNA helicase as an anti-neoplastic approach
Chu, J., & Pelletier, J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.006 · Cited by 80
Self-citationDepletion of eIF4G from yeast cells narrows the range of translational efficiencies genome-wide
Park, E.-H., Zhang, F., Warringer, J., Sunnerhagen, P., & Hinnebusch, A. G. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-68 · Cited by 74
General RNA‐binding proteins have a function in poly(A)‐binding protein‐dependent translation
Svitkin, Y. V., Evdokimova, V. M., Brasey, A., Pestova, T. V., Fantus, D., Yanagiya, A., Imataka, H., Skabkin, M. A., Ovchinnikov, L. P., Merrick, W. C., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.259 · Cited by 74
Self-citationBi, X., & Goss, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909464199 · Cited by 73
Edery, I., Lee, K. A. W., & Sonenberg, N. (1984) · Biochemistry · doi:10.1021/bi00306a021 · Cited by 73
Self-citationKroczyńska, B., Kaur, S., Katsoulidis, E., Majchrzak-Kita, B., Sassano, A., Kozma, S. C., Fish, E. N., & Platanias, L. C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01537-08 · Cited by 73
Jemielity, J., Kowalska, J., Rydzik, A. M., & Darżynkiewicz, E. (2010) · New Journal of Chemistry · doi:10.1039/c0nj00041h · Cited by 73
Slepenkov, S. V., Darżynkiewicz, E., & Rhoads, R. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601653200 · Cited by 71
Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A
Cencic, R., Robert, F., Galicia-Vázquez, G., Malina, A., Kontham, R., Somaiah, R., Pierre, P., Tanaka, J., Deslongchamps, P., & Pelletier, J. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.25 · Cited by 70
Self-citationRNA-binding activity of translation initiation factor eIF4G1 from Saccharomyces cerevisiae
Berset, C., Zurbriggen, A., Djafarzadeh, S., Altmann, M., & Trachsel, H. (2003) · RNA · doi:10.1261/rna.5380903 · Cited by 68
Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
Kogure, T., Kinghorn, A. D., Yan, I. K., Bolon, B. N., Lucas, D. M., Grever, M. R., & Patel, T. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076136 · Cited by 68
Emerging Therapeutics Targeting mRNA TranslationPreprint
Malina, A., Mills, J. R., & Pelletier, J. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012377 · Cited by 68
Self-citationBi, X., Ren, J., & Goss, D. J. (2000) · Biochemistry · doi:10.1021/bi992322p · Cited by 67
Thomas, A. A. M., GOUMANS, H., AMESZ, H., Benne, R., & Voorma, H. O. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb13192.x · Cited by 67
Jiang, Y., & Muschel, R. J. (2002) · PubMed · Cited by 66
Zuberek, J., Jemielity, J., Jabłonowska, A., Stȩpiński, J., Dadlez, M., Stolarski, R., & Darżynkiewicz, E. (2004) · Biochemistry · doi:10.1021/bi030266t · Cited by 65
Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma
Robert, F., Roman, W., Bramoullé, A., Fellmann, C., Roulston, A., Shustik, C., Porco, J. A., Shore, G. C., Sebag, M., & Pelletier, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402650111 · Cited by 64
Self-citationLarsson, O. S., Perlman, D., Fan, D., Reilly, C., Peterson, M., Dahlgren, C., Liang, Z., Li, S., Polunovsky, V. A., Wahlestedt, C., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl558 · Cited by 64
Characterization of the 46,000-Dalton subunit of eIF-4F
Conroy, S. C., Dever, T. E., Owens, C. L., & Merrick, W. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90130-q · Cited by 63
Tschopp, C., Knauf, U., Brauchle, M. A., Zurini, M. G. M., Ramage, P., Glück, D., New, L., Han, J., & Gram, H. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0217 · Cited by 63
Morgan, M. A., & Shatkin, A. J. (1980) · Biochemistry · doi:10.1021/bi00567a003 · Cited by 62
Single-Molecule Kinetics of the Eukaryotic Initiation Factor 4AI upon RNA Unwinding
Sun, Y., Atas, E., Lindqvist, L., Sonenberg, N., Pelletier, J., & Meller, A. (2014) · Structure · doi:10.1016/j.str.2014.04.014 · Cited by 56
Self-citationPelletier, J., & Sonenberg, N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3222 · Cited by 56
Self-citationPreferential stimulation of rabbit α globin mRNA translation by a cap-binding protein complex
Sarkar, G., Edery, I., Gallo, R., & Sonenberg, N. (1984) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(84)90003-4 · Cited by 55
Self-citationCap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking
Lindqvist, L., Imataka, H., & Pelletier, J. (2008) · RNA · doi:10.1261/rna.971208 · Cited by 55
Self-citationExpression of eIF4E During Head and Neck Tumorigenesis: Possible Role in Angiogenesis
Nathan, C. O., Franklin, S. W., Abreo, F. W., Nassar, R., Benedetti, A. D., Williams, J., & Stucker, F. J. (1999) · The Laryngoscope · doi:10.1097/00005537-199908000-00013 · Cited by 54
Cited by
Sorted by citations
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378
“Of the four phases of protein synthesis (initiation, elongation, termination, and recycling), initiation is considered to be the rate-limiting step in mRNA translation and is often exploited by cancer cells to support tumorigenesis (Pelletier et al., 2015).”
InfluentialSelf-citationGenome editing of upstream open reading frames enables translational control in plants
Zhang, H., Si, X., Ji, X., Fan, R., Liu, J., Chen, K., Wang, D., & Gao, C. (2018) · Nature Biotechnology · doi:10.1038/nbt.4202 · Cited by 373
Translation from unconventional 5′ start sites drives tumour initiation
Sendoel, A., Dunn, J. G., Rodriguez, E. H., Naik, S., Gomez, N. C., Hurwitz, B. S., Levorse, J. M., Dill, B. D., Schramek, D., Molina, H., et al. (2017) · Nature · doi:10.1038/nature21036 · Cited by 339
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
Metadata
- Authors
- Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N.
- Affiliations
- Institut du cancer Rosalind & Morris Goodman (CA)
- Eli Lilly (United States) (US)
- University of California, San Francisco (US)
- Corresponding author
- Pelletier, Jerry
- Venue
- Cancer Research
- Published
- 2015-01-14
- Volume
- 75
- Issue
- 2
- Pages
- 250-263
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC4299928
- OpenAlex
- W2005176113
- Cited by
- 367
- References
- 227
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 30 · 2023: 36 · 2022: 30 · 2021: 39 · 2020: 32 · 2019: 35 · 2018: 40 · 2017: 33 · 2016: 37 · 2015: 19
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Public Health Service (MOP-106530, MOP-115126)
- National Cancer Institute (R01CA140456, R01CA184624, R01CA154916)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- eIF4F, translation initiation, cancer, translational regulation, oncogenic signaling, Ras, c-Myc, metastasis, epithelial-mesenchymal transition, angiogenesis, cell proliferation
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, Eukaryotic Initiation Factor-4F, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review